0001209191-24-003958.txt : 20240226 0001209191-24-003958.hdr.sgml : 20240226 20240226175434 ACCESSION NUMBER: 0001209191-24-003958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240222 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duncan Barbara Gayle CENTRAL INDEX KEY: 0001353128 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 24680728 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES STREET CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 441 NINTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 441 NINTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-22 0 0001636651 Ovid Therapeutics Inc. OVID 0001353128 Duncan Barbara Gayle C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE NEW YORK NY 10001 1 0 0 0 0 Stock Option (Right to Buy) 3.68 2024-02-22 4 A 0 30000 0.00 A 2034-02-21 Common Stock 30000 30000 D The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date. /s/ Danielle Mann for Barbara Duncan by POA 2024-02-26